Acetazolamide

This page shows anti-doping rule violation data we have registered for Acetazolamide.

Number of cases in Acetazolamide Last 10 Years

Acetazolamide

Acetazolamide ranks #84 globally among prohibited substances, with 29 registered cases (0.2% of all violations) among all sports tracked by the Anti-Doping Database, which contains 14,710 verified cases. Russia leads with 9 cases, while Track and field is the most affected sport (7 cases).

Cases of Acetazolamide by Sport
Track and field
7
Cycling
5
Boxing
3
Swimming
3
Fitness
1
Top Sport: Track and field

7

Track and field cases

0%

Of all violations

29

Total Acetazolamide cases
Track and field's share of Acetazolamide violations 0%
7 of 29

Track and field has the most recorded cases of Acetazolamide violations globally, with 7 registered cases — 0% of all 29 verified cases.

Cases of Acetazolamide by Country
Russia
9
India
5
Azerbaijan
2
Cuba
2
USA
2
Top Country: Russia

9

Russia cases

31%

Of all violations

29

Total Acetazolamide cases
Russia's share of Acetazolamide violations 31%
9 of 29

Russia leads significantly in Acetazolamide violations globally, with 9 registered cases — 31% of all 29 verified cases.

Global Substance Ranking

Acetazolamide ranks #84 of 358 prohibited substances in the Anti-Doping Database.

#1 Stanozolol
1,364
#2 Methandienone
835
#3 Norandrosterone
781
#4 Testosterone
758
···
#84 Acetazolamide
29
About This Ranking

This ranking covers only prohibited substances with verified case records in the Anti-Doping Database. Procedural violations (whereabouts failures, refusals to test, etc.) are excluded.

Active Sanctions — Expiry Year
Gender Distribution
Male 51.7%
15 cases
Female 48.3%
14 cases
Analysis: shows an unusually high proportion of female cases (48.3%) compared to the global average (19.8%), a difference of 28.5 percentage points. Global average: 80.2% male, 19.8% female
Average Suspension Length
18.2
months
Acetazolamide
30.1
months
Global average

The average suspension for Acetazolamide violations is 18.2 months, shorter than the global average of 30.1 months.

Acetazolamide is used in the treatment of glaucoma, drug-induced edema, heart failure-induced edema, epilepsy and in reducing intraocular pressure after surgery. It has also been used in the treatment of altitude sickness, Ménière's disease, increased intracranial pressure and neuromuscular disorders. The substance reduces the activity of a protein in your body called carbonic anhydrase. Blocking this protein can help reduce the build-up of certain fluids in the body. It is used in people with certain types of glaucoma to reduce the amount of fluid in the eye, which decreases pressure inside the eye. Acetazolamide is also used as a diuretic ("water pill") in people with congestive heart failure, to reduce the build-up of fluid in the body. This build-up is called edema. (Source: Wikipedia and Drugs.com) This substance was added to the doping list ahead of the Seoul 1988 Olympic Games.

If you use this data, please credit The Anti-Doping Database

The intelligence tool for anti-doping professionals

Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.

 

As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:

  • Complete athlete and sanction details
    • Identity, ban periods, substances used, test type, violation information and more.
  • Verified documents and case materials
    • Access sanction decisions, PDFs and official sources when available.
  • Advanced insights and historical trends
    • Statistics across sports, countries, substances and year-by-year comparisons — for proactive planning, not just post-case analysis.

The Anti-Doping Database currently contains 14,710 verified anti-doping rule violations across all sports and all countries, and is updated regularly.